---
title: "Systemic Lupus Erythematosus"
canonical: "https://www.pharmalegacy.com/indications/inflammation-immunity-autoimmunity/systemic-lupus-erythematosus/"
lastmod: "2026-07-02T15:38:59+00:00"
generator: "llm-mirrors/1.0.19"
---

Systemic Lupus Erythematosus (SLE) is characterized by the excessive production of autoantibodies and their deposition in a variety of organs (namely the kidneys and skin). Being an idiopathic multisystem autoimmune disease, SLE’s etiology is considered to be multifactorial and is still poorly understood.
Finding cures and treatments for multifactorial autoimmune disease like SLE is a task that demands excellence in the tiniest of details, from data collection all the way to proper model selection. A task our team of experts at PharmaLegacy has been trained for years to handle. Keep scrolling to get more information on our SLE in MRL/Ipr and NZB/W F1 mice and our Pristane induced SLE in wild and humanized mice models.